Sign in
TerminatedPhase 4

Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure

Key facts

Who runs it
Radha Gopalan
Where
Phoenix, United StatesSee the site
Trial code
Status
Terminated
Phase
Phase 4
People taking part
6 people enrolled
Started
24 Jan 2024
Ended
18 Nov 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • IV Iron Infusion Group
Record updated
29 July 2026
Why it stopped
Difficulty with accrual.

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Age 18-90 years
  • New York Heart Association Class II-III heart failure
  • Left ventricular dysfunction with left ventricular ejection fraction ≤ 40%
  • Ferritin < 100 ng/mL or 100-300 ng/mL with transferrin saturation (TSAT) < 20%
  • Patients deemed by an attending physician to require intravenous iron therapy
  • The patient is willing and able to comply with the protocol and has provided written informed consent

Who cannot take part

  • Iron overload disorders or allergy, concomitant nutritional deficiencies- B12 and folate
  • Recent Acute Coronary Syndrome
  • Currently presenting in heart failure exacerbation
  • Chronic liver disease
  • Active bleeding
  • Physical barriers to exercise capacity
  • Declined participation
  • NYHA class IV
  • Pregnancy
  • Life expectancy ≤ 12 months

Where in United States

  • Banner - University Medical Center, Phoenix campusPhoenix, United States

About the trial

What the trial wants to find out

Patients with heart failure with reduced ejection fraction and iron deficiency will be randomized to either receive iron infusion or be in the control group. The study is looking at how iron replacement affects exercise capacity as measured by peak oxygen uptake.

The 2 groups in the trial

  • IV Iron Infusion GroupTreatment being tested

    Subjects will receive iron infusion 1 week after enrollment. Dosage of iron will be at discretion of physicians

  • Control GroupNo study treatment, for comparison

    Subjects will not receive iron replacement infusion.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure With Reduced Ejection Fraction and Iron Deficiency
Record updated
29 July 2026